Low treatment initiation rates among multidrug-resistant tuberculosis patients in Gauteng, South Africa, 2011

被引:22
作者
Ebonwu, J. I. [1 ]
Tint, K. S. [1 ,2 ]
Ihekweazu, C. [3 ,4 ]
机构
[1] Natl Inst Communicable Dis, South African Field Epidemiol & Lab Training Prog, ZA-2132 Johannesburg, South Africa
[2] Univ Pretoria, Sch Hlth Syst & Publ Hlth, ZA-0002 Pretoria, South Africa
[3] Natl Inst Communicable Dis, Ctr TB, Natl Hlth Lab Serv, Pretoria, South Africa
[4] Hlth Protect Agcy, London, England
关键词
MDR-TB transmission; patient tracing; untreated patients; risk markers; death; MDR-TB; PULMONARY TUBERCULOSIS; TREATMENT OUTCOMES; DELAY;
D O I
10.5588/ijtld.13.0071
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
SETTING: Gauteng, South Africa. OBJECTIVE: To determine treatment uptake among newly diagnosed multidrug-resistant tuberculosis (MDR-TB) patients and risk markers for non-initiation of treatment. DESIGN: A cross-sectional study was conducted including all newly diagnosed MDR-TB patients in Gauteng Province, South Africa, in 2011. Socio-demographic and clinical characteristics of those who attended Sizwe Hospital, the designated MDR-TB hospital, were extracted from their medical records. District health offices provided data on patients not seen at Sizwe Hospital. Univariate and multivariate analysis were used to determine risk markers for non-initiation of treatment. RESULTS: Of the 942 newly diagnosed MDR-TB patients in Gauteng, only 593 (63%) initiated treatment. Of these, 70 (11.8%) did not maintain treatment up to the fourth month. Among the 349 (37%) who did not initiate treatment, 31.2% died and 46.4% could not be accounted for. Referral for laboratory diagnosis from hospitals, health district of the laboratory diagnosis, human immunodeficiency virus infection and place of residence were independently associated with non-initiation of MDR-TB treatment. CONCLUSION: Untreated patients continue to transmit MDR-TB in the community. These study findings highlight the need to identify and target the causes of non-initiation of treatment in specific settings.
引用
收藏
页码:1043 / 1048
页数:6
相关论文
共 23 条
  • [1] [Anonymous], 2011, SCAL DIAGN TREATM DR
  • [2] Brust JCM, 2010, INT J TUBERC LUNG D, V14, P413
  • [3] Causes of Death in HIV-infected Persons Who Have Tuberculosis, Thailand
    Cain, Kevin P.
    Anekthananon, Thanomsak
    Burapat, Channawong
    Akksilp, Sornsalk
    Mankhatitham, Wiroj
    Srinalk, Chawin
    Nateniyom, Sriprapa
    Sattayawuthipong, Wanchai
    Tasaneeyapan, Theerawit
    Varma, Jay K.
    [J]. EMERGING INFECTIOUS DISEASES, 2009, 15 (02) : 258 - 264
  • [4] Delayed treatment of diagnosed pulmonary tuberculosis in Taiwan
    Chern, Jimmy P. S.
    Chen, Duan-Rung
    Wen, Tzai-Hung
    [J]. BMC PUBLIC HEALTH, 2008, 8 (1)
  • [5] Multidrug-Resistant Tuberculosis Treatment Outcomes in Karakalpakstan, Uzbekistan: Treatment Complexity and XDR-TB among Treatment Failures
    Cox, Helen S.
    Kalon, Stobdan
    Allamuratova, Sholpan
    Sizaire, Vinciane
    Tigay, Zinaida N.
    Ruesch-Gerdes, Sabine
    Karimovich, Hamraev A.
    Kebede, Yared
    Mills, Clair
    [J]. PLOS ONE, 2007, 2 (11):
  • [6] Patient and health care system delays in the start of tuberculosis treatment in Norway
    Farah, MG
    Rygh, JH
    Steen, TW
    Selmer, R
    Heldal, E
    Bjune, G
    [J]. BMC INFECTIOUS DISEASES, 2006, 6 (1)
  • [7] Golub JE, 2006, INT J TUBERC LUNG D, V10, P24
  • [8] Predictors of poor treatment outcome in multi- and extensively drug-resistant pulmonary TB
    Kliiman, K.
    Altraja, A.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2009, 33 (05) : 1085 - 1094
  • [9] Koomhof H, 2011, COMMUN DIS SURVEILL, V9, P68
  • [10] Pulmonary Tuberculosis and Delay in Anti-Tuberculous Treatment Are Important Risk Factors for Chronic Obstructive Pulmonary Disease
    Lee, Chih-Hsin
    Lee, Ming-Chia
    Lin, Hsien-Ho
    Shu, Chin-Chung
    Wang, Jann-Yuan
    Lee, Li-Na
    Chao, Kun-Mao
    [J]. PLOS ONE, 2012, 7 (05):